Nordea Investment Management AB grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 6.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 43,921 shares of the medical equipment provider’s stock after purchasing an additional 2,549 shares during the quarter. Nordea Investment Management AB’s holdings in Intuitive Surgical were worth $23,632,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of ISRG. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the first quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the first quarter worth about $30,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new stake in Intuitive Surgical during the first quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Price Performance
Intuitive Surgical stock opened at $446.13 on Friday. The firm has a 50 day simple moving average of $454.97 and a 200-day simple moving average of $495.75. The stock has a market capitalization of $159.93 billion, a PE ratio of 62.22, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on ISRG shares. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Piper Sandler restated an “overweight” rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Finally, The Goldman Sachs Group decreased their target price on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $580.29.
Insider Activity
In other news, Director Amy L. Ladd sold 336 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last three months. Corporate insiders own 0.70% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- What Are Earnings Reports?
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.